About Natrix Separations
Natrix Separations is a company based in Darmstadt (Germany) founded in 2004 was acquired by Merck Millipore in August 2017. Natrix Separations has raised $20.71 million across 4 funding rounds from investors including D. E. Shaw Group, Oxford Finance and Merck Millipore. Natrix Separations operates in a competitive market with competitors including ChromaTan, Upfront Chromatography, Sepax Technologies, Reach Separations and PharmaFluidics, among others.
- Headquarter Darmstadt, Germany
-
Sectors
Healthcare
-
Email
Locked
-
Phone
Locked
-
Website
Locked
-
Social
Locked
-
Annual Revenue
Not available
-
Net Profit
Not available
-
EBITDA
Not available
-
Total Equity Funding
$20.71 M (USD)
in 4 rounds
-
Latest Funding Round
$8 M (USD), Debt – Venture
Jul 22, 2014
-
Investors
D. E. Shaw Group
& 4 more
-
Employee Count
Not available
-
Acquired by
Merck Millipore
(Aug 28, 2017)
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Funding Insights of Natrix Separations
Natrix Separations has successfully raised a total of $20.71M across 4 strategic funding rounds. The most recent funding activity was a Debt – Venture round of $8 million completed in July 2014. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
Investors in Natrix Separations
Natrix Separations has secured backing from 5 investors, including venture fund and institutional investors. Prominent investors backing the company include D. E. Shaw Group, Oxford Finance and Merck Millipore.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Venture debt firm focused on the life sciences sector
|
Locked | Locked | Locked | |
|
It serves as a government backed investment fund focused on the economic growth of southern ontorio.
|
Locked | Locked | Locked | |
|
Multinational investment management services are provided globally.
|
Locked | Locked | Locked |
Investor details for Natrix Separations
Investor domains, locations, round participation, and complete history require an active premium plan.
- Investor domains
- Investor locations
- Funding rounds
- Participation history
Verified entity values are shown only after access is granted.
Investments & Acquisitions by Natrix Separations
Investment portfolio details for Natrix Separations
Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.
- Portfolio identities
- Transaction dates
- Round details
- Investment values
Verified entity values are shown only after access is granted.
Financial Statements - Natrix Separations
Detailed financials for Natrix Separations
Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.
- Historical revenue
- Profit trends
- Statement rows
- Financial ratios
Verified entity values are shown only after access is granted.
Natrix Separations Comparisons
Peer comparison for Natrix Separations
Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.
- Named peers
- Headcount comparison
- Funding comparison
- Operating benchmarks
Verified entity values are shown only after access is granted.
Competitors of Natrix Separations
Natrix Separations operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as ChromaTan, Upfront Chromatography, Sepax Technologies, Reach Separations and PharmaFluidics, among others.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| Locked | Locked | Locked |
Continuous countercurrent tangential chromatography separation technology is developed.
|
|
| Locked | Locked | Locked |
Chromatography technologies for protein separation and biomolecule recovery are provided.
|
|
| Locked | Locked | Locked |
Solutions for chromatographic biomolecular separation are developed and provided.
|
|
| Locked | Locked | Locked |
Small molecule analysis and purification services are provided using chromatography.
|
|
| Locked | Locked | Locked |
Microchip liquid chromatography cartridges are supplied for nano-LC applications.
|
Detailed competitors of Natrix Separations
Competitor domains, locations, full profiles, and operating metrics require an active premium plan.
- Domains and locations
- Full company profiles
- Operating metrics
- Competitive positioning
Verified entity values are shown only after access is granted.
Latest news on Natrix Separations
Complete news archive for Natrix Separations
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Natrix Separations
Natrix Separations was founded in 2004 and raised its 1st funding round 1 year after it was founded.
Natrix Separations is headquartered in Darmstadt, Germany. It is registered at Darmstadt, Hesse, Germany.
Natrix Separations is a funded company, having raised a total of $20.71M across 4 funding rounds to date.
Natrix separations specializes in developing single use and multi-cycle disposable chromatography products for downstream applications in biopharmaceutical manufacturing. Their proprietary Natrix HD Membranes offer features such as high functional binding group density, readily accessible functional groups, and multi-point molecular binding and thus help in overcoming efficiency, speed, and flexibility barriers which come with conventional chromatography approach. Their purification platform leverages the high binding capacity of resin-based chromatography with the high throughput and ease of use of traditional membrane adsorbers.
Natrix Separations's top competitors include ChromaTan, Sepragen and Sepax Technologies.
Natrix Separations has 5 investors. Key investors include D. E. Shaw Group, Oxford Finance, Merck Millipore, BDC, and FedDev Ontario.